CAMBRIDGE, Mass., Aug. 09, 2022 (GLOBE NEWSWIRE) Third Harmonic Bio, Inc., a clinical-stage biopharmaceutical company developing a potent, highly selective, oral KIT inhibitor for the treatment of severe allergy
Investment Analysts’ upgrades for Friday, June 3rd: ABC-Mart,Inc. (OTCMKTS:AMKYF) was upgraded by analysts at Daiwa Capital Markets from a neutral rating to an outperform rating. Brenntag (OTCMKTS:BNTGY) was upgraded by analysts at Baader Bank to a buy rating. Ciena (NYSE:CIEN) was upgraded by analysts at B. Riley from a neutral rating to a buy rating. […]
/PRNewswire/ Polaris Market Research recently published a research report on "Buccal Drug Delivery System Market Share, Size, Trends, Industry Analysis.